Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases
Paula M. Soriano‐Teruel(Centro de Investigacion Principe Felipe), Mar Orzáez(Centro de Investigacion Principe Felipe)
Cited by 67
Related Papers
MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications
|Nanomedicine Nanotechnology Biology and Medicine|2017|108
Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic
|Journal of Controlled Release|2020|106